AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Pituitary Neoplasms

Showing 41 to 50 of 61 articles

Clear Filters

A Novel Method for Classifying Liver and Brain Tumors Using Convolutional Neural Networks, Discrete Wavelet Transform and Long Short-Term Memory Networks.

Sensors (Basel, Switzerland)
Rapid classification of tumors that are detected in the medical images is of great importance in the early diagnosis of the disease. In this paper, a new liver and brain tumor classification method is proposed by using the power of convolutional neur...

Preoperative evaluation of tumour consistency in pituitary macroadenomas: a machine learning-based histogram analysis on conventional T2-weighted MRI.

Neuroradiology
PURPOSE: To evaluate the potential value of machine learning (ML)-based histogram analysis (or first-order texture analysis) on T2-weighted magnetic resonance imaging (MRI) for predicting consistency of pituitary macroadenomas (PMA) and to compare it...

Machine learning defined diagnostic criteria for differentiating pituitary metastasis from autoimmune hypophysitis in patients undergoing immune checkpoint blockade therapy.

European journal of cancer (Oxford, England : 1990)
PURPOSE: New-onset pituitary gland lesions are observed in up to 18% of cancer patients undergoing treatment with immune checkpoint blockers (ICB). We aimed to develop and validate an imaging-based decision-making algorithm for use by the clinician t...

Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning.

Neuroradiology
PURPOSE: Pituitary adenomas are among the most frequent intracranial tumors. They may exhibit clinically aggressive behavior, with recurrent disease and resistance to multimodal therapy. The ki-67 labeling index represents a proliferative marker whic...

An enhanced deep learning approach for brain cancer MRI images classification using residual networks.

Artificial intelligence in medicine
Cancer is the second leading cause of death after cardiovascular diseases. Out of all types of cancer, brain cancer has the lowest survival rate. Brain tumors can have different types depending on their shape, texture, and location. Proper diagnosis ...

A machine learning model to precisely immunohistochemically classify pituitary adenoma subtypes with radiomics based on preoperative magnetic resonance imaging.

European journal of radiology
PURPOSE: The type of pituitary adenoma (PA) cannot be clearly recognized with preoperative magnetic resonance imaging (MRI) but can be classified with immunohistochemical staining after surgery. In this study, a model to precisely immunohistochemical...

Machine learning applications in imaging analysis for patients with pituitary tumors: a review of the current literature and future directions.

Pituitary
PURPOSE: To provide an overview of fundamental concepts in machine learning (ML), review the literature on ML applications in imaging analysis of pituitary tumors for the last 10 years, and highlight the future directions on potential applications of...

Pituitary Tumors in the Computational Era, Exploring Novel Approaches to Diagnosis, and Outcome Prediction with Machine Learning.

World neurosurgery
BACKGROUND: Machine learning has emerged as a viable asset in the setting of pituitary surgery. In the past decade, the number of machine learning models developed to aid in the diagnosis of pituitary lesions and predict intraoperative and postoperat...

Prediction of pituitary adenoma surgical consistency: radiomic data mining and machine learning on T2-weighted MRI.

Neuroradiology
PURPOSE: Pituitary macroadenoma consistency can influence the ease of lesion removal during surgery, especially when using a transsphenoidal approach. Unfortunately, it is not assessable on standard qualitative MRI. Radiomic texture analysis could he...

MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas.

Computers in biology and medicine
Twelve to 66% of patients with clinically non-functioning pituitary adenoma (NFPA) experience tumor recurrence 1-5 years after the first surgery. Nevertheless, there is still no recurrence prediction factor concisely established and reproduced in the...